SENZAR ASSET MANAGEMENT, LLC historic quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), over 11 quarters from 2013-12-31 to 2016-09-30, SENZAR ASSET MANAGEMENT, LLC opened 35 positions, added to 23, reduced 20 and sold out of 33.
- Q3 2016: Stock ELV; Country of operation United States; Class COM; Shares before 143,800.
- Q3 2016: Stock MOH; Country of operation United States; Class COM; Shares before 150,700.
- Q3 2016: Stock ENTA; Country of operation United States; Class COM; Shares before 482,000.
- Q2 2016: Stock UHS; Country of operation United States; Class CL B; Shares before 89,500.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1579853), 11 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | ELV
ANTHEM INC | United States | COM | 143,800 | 219,200 | +75,400 | $18,886,692,000 | $27,467,952,000 | +$8,581,260,000 | 2016-11-14 |
|---|
| Q3 2016 | MOH
MOLINA HEALTHCARE INC | United States | COM | 150,700 | 179,700 | +29,000 | $7,519,930,000 | $10,480,104,000 | +$2,960,174,000 | 2016-11-14 |
|---|
| Q3 2016 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 482,000 | 506,900 | +24,900 | $10,628,100,000 | $13,488,609,000 | +$2,860,509,000 | 2016-11-14 |
|---|
| Q2 2016 | UHS
UNIVERSAL HLTH SVCS INC | United States | CL B | 89,500 | 114,700 | +25,200 | $11,162,440,000 | $15,381,270,000 | +$4,218,830,000 | 2016-08-12 |
|---|
| Q2 2016 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 338,851 | 482,000 | +143,149 | $9,952,054,000 | $10,628,100,000 | +$676,046,000 | 2016-08-12 |
|---|
| Q1 2016 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 163,986 | 338,851 | +174,865 | $5,414,818,000 | $9,952,054,000 | +$4,537,236,000 | 2016-05-13 |
|---|
| Q1 2016 | SEM
SELECT MED HLDGS CORP | United States | COM | 492,000 | 646,624 | +154,624 | $5,859,720,000 | $7,636,629,000 | +$1,776,909,000 | 2016-05-13 |
|---|
| Q1 2016 | INSM
INSMED INC | United States | COM PAR $.01 | 689,107 | 1,104,998 | +415,891 | $12,507,292,000 | $14,000,325,000 | +$1,493,033,000 | 2016-05-13 |
|---|
| Q4 2015 | ANIP
ANI PHARMACEUTICALS INC | United States | COM | 270,040 | 453,852 | +183,812 | $10,669,280,000 | $20,480,072,000 | +$9,810,792,000 | 2016-02-12 |
|---|
| Q4 2015 | INSM
INSMED INC | United States | COM PAR $.01 | 575,407 | 689,107 | +113,700 | $10,685,308,000 | $12,507,292,000 | +$1,821,984,000 | 2016-02-12 |
|---|
| Q3 2015 | INSM
INSMED INC | United States | COM PAR $.01 | 464,307 | 575,407 | +111,100 | $11,338,000 | $10,685,308,000 | +$10,673,970,000 | 2015-11-16 |
|---|
| Q1 2015 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 44,117 | 154,300 | +110,183 | $2,243,000 | $4,725,000 | +$2,482,000 | 2015-05-15 |
|---|
| Q4 2014 | CYH
COMMUNITY HEALTH SYS INC NEW | United States | COM | 314,700 | 435,100 | +120,400 | $17,243,000 | $23,461,000 | +$6,218,000 | 2015-02-17 |
|---|
| Q4 2014 | BIIB
BIOGEN IDEC INC | United States | COM | 26,800 | 37,800 | +11,000 | $8,865,000 | $12,831,000 | +$3,966,000 | 2015-02-17 |
|---|
| Q4 2014 | INSM
INSMED INC | United States | COM PAR $.01 | 663,300 | 677,600 | +14,300 | $8,656,000 | $10,482,000 | +$1,826,000 | 2015-02-17 |
|---|
| Q3 2014 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 255,128 | 566,903 | +311,775 | $10,988,000 | $22,432,000 | +$11,444,000 | 2014-11-14 |
|---|
| Q3 2014 | ABBV
ABBVIE INC | United States | COM | 309,595 | 431,400 | +121,805 | $17,474,000 | $24,918,000 | +$7,444,000 | 2014-11-14 |
|---|
| Q2 2014 | ENTA
ENANTA PHARMACEUTICALS INC | United States | COM | 141,128 | 255,128 | +114,000 | $5,644,000 | $10,988,000 | +$5,344,000 | 2014-08-14 |
|---|
| Q2 2014 | CYH
COMMUNITY HEALTH SYS INC NEW | United States | COM | 396,400 | 421,400 | +25,000 | $15,527,000 | $19,119,000 | +$3,592,000 | 2014-08-14 |
|---|
| Q2 2014 | CAH
CARDINAL HEALTH INC | United States | COM | 89,100 | 95,700 | +6,600 | $6,235,000 | $6,562,000 | +$327,000 | 2014-08-14 |
|---|
| Q1 2014 | AMGN
AMGEN INC | United States | COM | 83,800 | 128,098 | +44,298 | $9,560,000 | $15,800,000 | +$6,240,000 | 2014-05-15 |
|---|
| Q1 2014 | CYH
COMMUNITY HEALTH SYS INC NEW | United States | COM | 293,600 | 396,400 | +102,800 | $11,529,000 | $15,527,000 | +$3,998,000 | 2014-05-15 |
|---|
| Q1 2014 | CAH
CARDINAL HEALTH INC | United States | COM | 69,400 | 89,100 | +19,700 | $4,637,000 | $6,235,000 | +$1,598,000 | 2014-05-15 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |